NARSAD Grantee and Colleagues Create New Model for Treatment of OCD

Stephanie Dulawa, Ph.D.
Stephanie Dulawa, Ph.D.

Currently, there is only one type of medication that has been shown to be effective in treating Obsessive-Compulsive Disorder (OCD). Serotonin Reuptake Inhibitors (SRIs), including clomipramine, have been shown to reduce symptoms in 40% - 60% of patients with OCD. Cognitive Behavioral Therapy (CBT) has also been shown to be effective.

“Now that we have this model, we actually could pursue these ideas for better treatments in a disease where there is only one successful pharmocological monotherapy,” said NARSAD Young Investigator Grantee Stephanie Dulawa, Ph.D.

Click here to read more